ExplorePopulationChildren
Population

Children

Also known as: Children
495 findings 42 papers 20 related entities View in graph →

Related entities

interventions
conditions
outcomes
studys

Findings (50 of 495)

None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
decline

Children of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta

Effect: decline; β = −0.35

Size: β = −0.35
None
decline

Children of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta

Effect: decline; β = −0.35

Size: β = −0.35
None
decline

Children of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta

Effect: decline; β = −0.35

Size: β = −0.35
None
decline

Children of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta

Effect: decline; β = −0.35

Size: β = −0.35
None
decline

Children of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta

Effect: decline; β = −0.35

Size: β = −0.35
None
decline

Children of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta

Effect: decline; β = −0.35

Size: β = −0.35
None
decline

Children of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta

Effect: decline; β = −0.35

Size: β = −0.35
None
decline

Children of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta

Effect: decline; β = −0.35

Size: β = −0.35
None
decline

Children of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta

Effect: decline; β = −0.35

Size: β = −0.35
None
decline

Children of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta

Effect: decline; β = −0.35

Size: β = −0.35
None
decline

Children of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta

Effect: decline; β = −0.35

Size: β = −0.35
None
decline

Children of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta

Effect: decline; β = −0.35

Size: β = −0.35
None
decline

Children of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta

Effect: decline; β = −0.35

Size: β = −0.35
None
decline

Children of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta

Effect: decline; β = −0.35

Size: β = −0.35
None
decline

Children of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta

Effect: decline; β = −0.35

Size: β = −0.35
None
decline

Children of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta

Effect: decline; β = −0.35

Size: β = −0.35
None
decline

Children of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta

Effect: decline; β = −0.35

Size: β = −0.35
None
decline

Children of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta

Effect: decline; β = −0.35

Size: β = −0.35
None
decline

Children of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta

Effect: decline; β = −0.35

Size: β = −0.35
None
decline

Children of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta

Effect: decline; β = −0.35

Size: β = −0.35
None
decline

Children of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta

Effect: decline; β = −0.35

Size: β = −0.35
None
decline

Children of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta

Effect: decline; β = −0.35

Size: β = −0.35
None
decline

Children of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta

Effect: decline; β = −0.35

Size: β = −0.35

Papers (42)